Glucotrack Inc (GCTK)
0.1680 x 8 0.1700 x 262
Pre-market by (Cboe BZX)
0.1745 -0.0305 (-14.88%) 03/31/25 [NASDAQ]
0.1680 x 8 0.1700 x 262
Pre-market 0.1700 -0.0045 (-2.58%) 07:09 ET
for Mon, Mar 31st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 0 | 0 | 0 | 0 | 208 |
Gross Profit | N/A | N/A | N/A | N/A | 208 |
Operating Expenses | 7,104 | 4,432 | 4,040 | 3,132 | 3,714 |
Operating Income | -7,104 | -4,432 | -4,040 | -3,132 | -3,506 |
Other Income | 7 | -3 | -27 | 436 | -10 |
Pre-tax Income | -7,097 | -4,435 | -4,067 | -2,696 | -3,516 |
Net Income Continuous | -7,097 | -4,435 | -4,067 | -2,696 | -3,516 |
Net Income | $-7,097 | $-4,435 | $-4,067 | $-2,696 | $-3,516 |
EPS Basic Total Ops | -38.00 | -29.00 | -26.00 | -19.00 | -26.01 |
EPS Basic Continuous Ops | -34.19 | -28.66 | -26.32 | -17.88 | -29.51 |
EPS Diluted Total Ops | -38.00 | -29.00 | -26.00 | -19.00 | -26.01 |
EPS Diluted Continuous Ops | -34.19 | -28.66 | -26.32 | -17.88 | -29.51 |
EPS Diluted Before Non-Recurring Items | -38.00 | -29.00 | N/A | N/A | N/A |
EBITDA(a) | $-7,091 | $-4,409 | $-3,998 | $-3,085 | $-3,455 |